Skip to content

The impact of sugammadex sodium on postoperative residual neuromuscular blockade and early recovery quality in asthma patients

The impact of sugammadex sodium on postoperative residual neuromuscular blockade and early recovery quality in asthma patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097855
Enrollment
Unknown
Registered
2025-02-26
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

Intervention Group:Sugammadex 0.2 mg/kg
Control Group:An equivalent volume of normal saline

Sponsors

Fourth Military Medical University Tangdu Hospital /The Second Affiliated Hospital of Air Force Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of the Global Initiative for Asthma Management and Prevention (2023 updated version); 2. Have a history of asthma and be in a stable control period; 3. BMI between 18-30 kg/m^2; 4. ASA classification I to III; 5. Voluntarily sign the informed consent form; 6. Age between 16-80 years old.

Exclusion criteria

Exclusion criteria: 1. Patients with difficult airways (e.g., mouth opening degree II or above, Mallampati classification III/IV); 2. Pregnant or lactating women; 3. Patients with respiratory failure, whether receiving mechanical ventilation or not; 4. Patients with severe liver or kidney dysfunction; 5. Patients with neurological or psychiatric disorders or mental abnormalities; 6. Patients with myasthenia gravis; 7. Patients with severe cardiovascular or cerebrovascular diseases.

Design outcomes

Primary

MeasureTime frame
Train-of-Four Ratio;

Secondary

MeasureTime frame
The Aldrete Modified Scoring System score 20 minutes after extubation;The Aldrete Modified Scoring System score 40 minutes after extubation.;The Quality of Recovery-40 (QoR-40) score 24 hours postoperatively;The Quality of Recovery-40 (QoR-40) score 48 hours postoperatively;Neuromuscular recovery time;Extubation time;The number of adverse events occurring within 72 hours postoperatively;The number of pulmonary complications occurring within 72 hours postoperatively;

Countries

China

Contacts

Public ContactChangjun Gao

Fourth Military Medical University Tangdu Hospital /The Second Affiliated Hospital of Air Force Military Medical University

gaocj74@163.com+86 29 8477 7439

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026